Financial statements Profarm Ps
Cash inflows of PROFARM PS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -523 357,81 | 9 405 169,36 | -4 300 231,37 | 2 700 431,57 | 9 114 299,06 | 6 283 368,07 |
| Net cash flow from investing activities | 52 187,75 | -3 613 459,12 | -279 786,79 | -337 442,70 | 55 212,54 | -885 851,90 |
| Net cash flow from financial activities | 785 577,59 | -417 335,87 | 586 714,23 | -3 178 421,00 | -8 255 609,78 | -4 392 194,62 |
| Total net cash flow | 314 407,53 | 5 374 374,37 | -3 993 303,93 | -815 432,13 | 913 901,82 | 1 005 321,55 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.